In a patient with recent weight loss and a CBC showing borderline normocytic anemia (hemoglobin 12.1 g/dL, hematocrit 38.2 %) with otherwise normal white‑blood‑cell, red‑blood‑cell, platelet counts and differential, what is the likely etiology and recommended diagnostic work‑up?

Borderline Normocytic Anemia with Recent Weight Loss: Diagnostic Approach

In this patient with borderline normocytic anemia (Hb 12.1 g/dL) and unexplained weight loss, the most critical next step is obtaining a reticulocyte count to distinguish between decreased red cell production versus increased destruction/loss, followed by iron studies (ferritin, transferrin saturation) and inflammatory markers (CRP), as this will guide whether to pursue malignancy workup, nutritional deficiencies, or chronic disease evaluation 1.

Immediate Diagnostic Algorithm

Step 1: Reticulocyte Count (Reticulocyte Index)

The reticulocyte index (RI) is the critical branching point for normocytic anemia (MCV 89.5 fL falls within 80-100 fL range) 1:

• Low RI (<1.0-2.0): Indicates decreased RBC production, suggesting:

  • Iron deficiency (even with normal MCV)
  • Vitamin B12/folate deficiency
  • Bone marrow dysfunction from malignancy
  • Anemia of chronic inflammation
  • Renal insufficiency

• High RI (>2.0): Indicates normal/increased production, suggesting:

  • Occult blood loss (GI bleeding)
  • Hemolysis

Step 2: Iron Studies and Inflammatory Markers

Order simultaneously with reticulocyte count 1, 2, 3:

• Serum ferritin
• Transferrin saturation (TSAT)
• CRP

Interpretation for iron deficiency 3:

• Without inflammation: Ferritin <30 μg/L = iron deficiency
• With inflammation (elevated CRP): Ferritin up to 100 μg/L may still indicate iron deficiency
• TSAT <20% with ferritin 30-100 μg/L = mixed iron deficiency and anemia of chronic disease

Step 3: Peripheral Blood Smear Review

Critical for identifying 1:

• RBC size, shape, and color confirmation
• Hypersegmented neutrophils (B12/folate deficiency)
• Schistocytes (hemolysis or pseudo-TMA from B12 deficiency)
• Teardrop cells (marrow infiltration)

Weight Loss Context: Malignancy Screening Priority

Given the unexplained weight loss, this significantly elevates concern for underlying malignancy 4:

If Low Reticulocyte Index + Normal/High Ferritin:

Pursue malignancy workup aggressively:

• Age-appropriate cancer screening (colonoscopy if ≥45 years or earlier with symptoms)
• Upper endoscopy with small bowel biopsy (to exclude gastric cancer, celiac disease) 4
• CT chest/abdomen/pelvis if constitutional symptoms persist
• Consider bone marrow biopsy if cytopenias in multiple cell lines develop

If Low Reticulocyte Index + Low Ferritin:

GI blood loss evaluation is mandatory 4:

• Both upper endoscopy AND colonoscopy (or barium enema if colonoscopy unavailable)
• Stool for occult blood
• In men and postmenopausal women, assume GI malignancy until proven otherwise

Additional Testing Based on Clinical Context

Nutritional Deficiencies (especially with weight loss):

• Vitamin B12 level (can present as normocytic before becoming macrocytic) 1, 5
• Folate level
• Methylmalonic acid (MMA) if B12 borderline (>1.56 μmol/L suggests true deficiency even with normal B12) 6

Critical pitfall: B12 levels may appear falsely normal in pernicious anemia due to intrinsic factor antibody interference with immunoassays 6. If clinical suspicion high (neurologic symptoms, glossitis), check intrinsic factor antibodies and MMA.

Renal Function:

• Creatinine and BUN (anemia of chronic kidney disease) 7
• Consider in context of any chronic disease

Thyroid Function:

• TSH (hypothyroidism causes normocytic anemia)

Common Pitfalls to Avoid

1. Don't assume normal MCV excludes iron deficiency: Early iron deficiency or combined deficiencies (iron + B12/folate) can present as normocytic 2. The elevated RDW (15.5%, upper limit of normal) suggests mixed cell populations.

2. Don't rely solely on ferritin in inflammatory states: Ferritin is an acute phase reactant and can be falsely elevated 1, 3. Use TSAT and consider functional iron deficiency.

3. Don't miss pseudo-TMA from B12 deficiency: Schistocytes, elevated LDH, low haptoglobin can mimic TTP but actually represent severe B12 deficiency 8, 6. Check B12/MMA before initiating plasma exchange.

4. Don't delay malignancy workup: In patients with unexplained weight loss and anemia, even mild anemia warrants aggressive investigation for GI malignancy 4.

5. Don't overlook medication history: NSAIDs cause occult GI bleeding; certain drugs cause macrocytosis or bone marrow suppression 1.

Clinical Significance of This Patient's Labs

• Hemoglobin 12.1 g/dL: Just at lower limit for women, warrants full evaluation 2
• RDW 15.5%: At upper limit, suggests heterogeneous RBC population (early deficiency or mixed pathology) 2
• MPV 10.5 fL (slightly elevated): May indicate increased platelet turnover; monitor for developing thrombocytopenia
• Normal WBC differential: Makes primary bone marrow disorder less likely but doesn't exclude it

Treatment Considerations

Do not initiate empiric iron therapy without establishing diagnosis 4, 9. Exceptions:

• Children 6-36 months with risk factors for iron deficiency may receive presumptive oral iron trial
• This adult patient with weight loss requires definitive diagnosis first

If iron deficiency confirmed: Investigate cause before treating, especially in men and postmenopausal women where GI malignancy must be excluded 4.

1, 2, 3, 2, 7, 4